Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Surface coating nanoarchitectonics for optimizing cytocompatibility and antimicrobial activity: The impact of hyaluronic acid positioning as the outermost layer.

Neto GLB., Quinalia TRB., de Almeida DA., Madruga LYC., Souza PR., Popat KC.

Laboratory Study on Face & Skin, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
39818370
DOI
10.1016/j.ijbiomac.2025.139908
Citations
1

Abstract (original English)

Polyelectrolyte multilayers (PEMs) based on hyaluronic acid (HA) and poly (diallyldimethylammonium chloride) (PDDA) were deposited on oxidized polystyrene (PS ox ) via the layer-by-layer (LbL) method. The X-ray photoelectron spectroscopy (XPS) confirmed the PEM deposition on PS ox , and atomic force microscopy (AFM) indicated that the surface roughness of PS also increased after PEM deposition. The PEMs significantly enhanced PS wettability, reducing the contact angle from 73° on PS to 24° on PDDA-terminated (PDDA/HA) 2.5 PEM (2.5 bilayers, 5 layers) and 36° on HA-terminated (PDDA/HA) 3 PEM (3 bilayers, 6 layers). The HA-terminated (PDDA/HA)₃ PEM demonstrated antimicrobial activity. Compared to uncoated PS surfaces, this PEM reduced the surface coverage of viable P. aeruginosa cells from 36.5 % to 3.7 % and S. aureus cells from 13.3 % to 2.5 % on uncoated PS surfaces. The antimicrobial assay following the JIS Z 2801-2010 standard demonstrated that the PDDA-terminated (PDDA/HA) 2.5 PEM inhibited S. aureus growth by 48 %, compared to 32 % inhibition by the HA-terminated (PDDA/HA) 3 PEM relative to the uncoated and non-oxidized polystyrene (PS) surface (control). HA-terminated PEM demonstrated lesser antimicrobial activity than PDDA-terminated PEM. However, both PEMs were cytocompatible against erythrocytes and human adipose-derived stem cells (ADSCs), indicating their potential f

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Hyaluronic AcidHumansSurface PropertiesPolystyrenesCoated Materials, BiocompatibleQuaternary Ammonium CompoundsPolyethylenesStaphylococcus aureusPseudomonas aeruginosaPolyelectrolytes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research